Zionexa Overview
- Year Founded
-
1998
- Status
-
Acquired/Merged
- Employees
-
24
- Latest Deal Type
-
M&A
Zionexa General Information
Description
Developer of molecular imaging technology designed to diagnose metastatic breast cancer. The company's technology provides physicians with new ways to look inside the human body by delivering images of remarkable clarity to identify the disease in its earliest stages and determine the exact location of a tumor, thereby helping doctors to personalize patient care within the framework of new personalized diagnostic approaches
Contact Information
Website
www.zionexa.comCorporate Office
- 42 Avenue de la Grande Armée
- 75017 Paris
- France
Corporate Office
- 42 Avenue de la Grande Armée
- 75017 Paris
- France
Zionexa Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 06-May-2021 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 11-Apr-2019 | Cancelled | Generating Revenue | |||
| 2. Early Stage VC | 11-Apr-2019 | $5.05M | $10.9M | Completed | Generating Revenue | |
| 1. Early Stage VC | 19-Sep-2018 | $5.81M | $5.81M | Completed | Startup |
Zionexa Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 2,018,208 | $1.128104 |
Zionexa Comparisons
Industry
Financing
Details
Zionexa Competitors (13)
One of Zionexa’s 13 competitors is Novus Biologicals, a Formerly PE-Backed company based in Centennial, CO.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Novus Biologicals | Formerly PE-Backed | Centennial, CO | ||||
| Adverum Biotechnologies | Formerly VC-backed | Redwood City, CA | ||||
| Kynexis | Venture Capital-Backed | Naarden, Netherlands | ||||
| Abcam | Corporate Backed or Acquired | Cambridge, United Kingdom | ||||
| Autogenomics | Formerly VC-backed | Carlsbad, CA |
Zionexa Patents
Zionexa Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| ES-2545536-T3 | Fluoride-18 labeling method of tropane derivatives | Inactive | 14-Nov-2006 | ||
| EP-1925615-A1 | Method of fluorine-18 labelling of tropane derivatives | Active | 14-Nov-2006 | ||
| EP-1925615-B1 | Method of fluorine-18 labelling of tropane derivatives | Inactive | 14-Nov-2006 | ||
| WO-2008059349-A1 | Method of fluorine-18 labelling of tropane derivatives | Inactive | 14-Nov-2006 | C07D451/02 |
Zionexa Signals
Zionexa Former Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Denos | Corporation | Minority | ||
| JEREMIE Auvergne | Venture Capital | Minority | ||
| Sofimac Investment Managers | Growth/Expansion | Minority | ||
| iXO Private Equity | PE/Buyout | Minority |
Zionexa FAQs
-
When was Zionexa founded?
Zionexa was founded in 1998.
-
Where is Zionexa headquartered?
Zionexa is headquartered in Paris, France.
-
What is the size of Zionexa?
Zionexa has 24 total employees.
-
What industry is Zionexa in?
Zionexa’s primary industry is Biotechnology.
-
Is Zionexa a private or public company?
Zionexa is a Private company.
-
What is Zionexa’s current revenue?
The current revenue for Zionexa is .
-
How much funding has Zionexa raised over time?
Zionexa has raised $10.9M.
-
Who are Zionexa’s investors?
Denos, JEREMIE Auvergne, Sofimac Investment Managers, and iXO Private Equity have invested in Zionexa.
-
Who are Zionexa’s competitors?
Novus Biologicals, Adverum Biotechnologies, Kynexis, Abcam, and Autogenomics are some of the 13 competitors of Zionexa.
-
When was Zionexa acquired?
Zionexa was acquired on 06-May-2021.
-
Who acquired Zionexa?
Zionexa was acquired by GE HealthCare Technologies.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process